These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10959719)

  • 1. Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men.
    Giltay EJ; Gooren LJ; Emeis JJ; Kooistra T; Stehouwer CD
    Thromb Haemost; 2000 Aug; 84(2):359-60. PubMed ID: 10959719
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in C-reactive protein levels induced by different application forms of estrogen replacement therapy].
    Fait T; Vrablík M; Kostírová M; Trnková B
    Cas Lek Cesk; 2006; 145(7):571-4; discussion 574. PubMed ID: 16921788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein--a cross-sectional population survey.
    Lowe GD; Upton MN; Rumley A; McConnachie A; O'Reilly DS; Watt GC
    Thromb Haemost; 2001 Aug; 86(2):550-6. PubMed ID: 11522002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting endothelial synthesis.
    Giltay EJ; Gooren LJ; Emeis JJ; Kooistra T; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1396-403. PubMed ID: 10807760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins].
    Uchikova E; Batashki I; Milchev N; Mateva N; Markova D; Gŭrova A
    Akush Ginekol (Sofiia); 2006; 45(2):39-43. PubMed ID: 16637303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
    Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
    Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of oral and transdermal hormone replacement therapy on C-reactive protein levels and other inflammatory markers in women with high risk of thrombosis.
    Eilertsen AL; Høibraaten E; Os I; Andersen TO; Sandvik L; Sandset PM
    Maturitas; 2005 Oct; 52(2):111-8. PubMed ID: 16186073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high dose oestrogen therapy on circulating inflammatory markers.
    Wilson R; Spiers A; Ewan J; Johnson P; Jenkins C; Carr S
    Maturitas; 2009 Mar; 62(3):281-6. PubMed ID: 19231116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals.
    Giltay EJ; Verhoef P; Gooren LJ; Geleijnse JM; Schouten EG; Stehouwer CD
    Atherosclerosis; 2003 May; 168(1):139-46. PubMed ID: 12732397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High C-reactive protein levels are associated with oral hormonal menopausal therapy but not with intrauterine levonorgestrel and transdermal estradiol.
    Blumenfeld Z; Boulman N; Leiba R; Siegler E; Shachar S; Linn R; Levy Y
    Scand J Clin Lab Invest; 2007; 67(3):257-63. PubMed ID: 17454839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
    Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
    Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW; Fisher AC; Hall N; Shangold GA
    J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
    J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
    Giltay EJ; Bunck MC; Gooren LJ; Zitman FG; Diamant M; Teerlink T
    Neuroendocrinology; 2008; 88(2):103-10. PubMed ID: 18511863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.